相关实验视频
Updated: Jul 12, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
对前列腺癌的分子洞察:选择性生物活性分子的预防作用
Mohd Jameel1, Homa Fatma1, Liudmila A Nadtochii2
1Molecular Cancer Genetics & Translational Research Lab, Section of Genetics, Department of Zoology, Aligarh Muslim University, Aligarh 202002, India.
前列腺癌 (CaP) 是一种常见的男性癌症. 本综述探讨了植物化学物质如何通过向癌症干细胞和克服抗化学性来帮助治疗CaP.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 前列腺癌 (CaP) 是男性死亡的主要原因,由于社会经济因素,诊断往往会延迟.
- 雄激素受体 (AR) 途径对CaP的发展和进展至关重要;雄激素剥夺疗法 (ADT) 是主要的治疗方法.
- 化学抵抗,通常是由癌症干细胞 (CSCs) 和瘤微环境信号驱动的,构成了重大的临床挑战.
研究的目的:
- 审查转移性前列腺癌 (CaP) 和化学抵抗的基础分子机制.
- 讨论植物化学物质在打击CaP启动,进展和耐化学物质方面的潜力.
主要方法:
- 文献综述专注于CaP中的分子途径.
- 对植物化学品对CaP细胞和化学抵抗的影响研究的分析.
- 检查癌症干细胞 (CSCs) 在治疗耐药性的作用.
主要成果:
- 植物化学物质显示出作为对CaP的化学保护剂和化学敏感剂的承诺.
- 这些化合物可以选择性地向恶性细胞,节省正常组织.
- 植物化学物质可以提供通过CSCs调解的克服化学抵抗的策略.
结论:
- 植物化学物质是前列腺癌新型治疗的有希望的途径.
- 用植物化学品向CSC和抗化学物质通路可以改善治疗结果.
- 对植物化学机制的进一步研究有必要在CaP治疗中进行临床应用.
更多相关视频
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Prevention
Some...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...